 SOUTH SAN FRANCISCO, Calif., Dec. 14, 2020 PRNewswire -- IDEAYA Biosciences, Inc. Nasdaq: IDYA, an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced today that it has been selected for addition to the NASDAQ... 